Josep-María Ribera (Jose-Maria Ribera, José-María Ribera, Josep Ribera, Josep Maria Ribera Santasusana, Josep María Ribera, Josep-Maria Ribera Santasusana, Josep Maria Ribera, Josep-Maria Ribera)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 60

Top Venues

Institut Català d'Oncologia Badalona

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Català d'Oncologia Badalona Jan 02 2003

Spain

Chief of the Department :: Clinical Hematology

Publications

Romain Guieze, Diderik-Jan Eikema, Linda Koster, Johannes Schetelig, Henrik Sengeloev, Jakob R Passweg, Juergen Finke, Mutlu Arat, Annoek E C Broers, Friedrich Stölzel, Jenny Byrne, Cristina Castilla-Llorente, Peter Dreger, Matthias Eder, Tobias Gedde-Dahl, Nicolaus M Kröger, Josep-María Ribera, Deborah Richardson, Alessandro Rambaldi, Lucrecia Yañez, Michel Van Gelder, Joanna Drozd-Sokołowska, Kavita Raj, Ibrahim Yakoub Agha, Olivier Tournilhac, Donal P McLornan
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Josep-María Ribera, Mireia Morgades, Jordi Ribera, Pau Montesinos, Isabel Cano-Ferri, Pilar Martínez, Jordi Esteve, Daniel Esteban, María García-Fortes, Natalia Alonso, José González-Campos, Arancha Bermúdez, Anna Torrent, Eulàlia Genescà, Clara Maluquer, Joaquín Martínez-López, Ramón García-Sanz
Ponalfil trial for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: Long-term results. HemaSphere 8 (4) (2024)
Amir Enshaei, Melvin Joy, Ellie Butler, Amy A Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J Harrison, Robin Foà, Josep-María Ribera, Sabina Chiaretti, Renato Bassan, Adele K Fielding, Anthony V Moorman
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study. Blood advances 8 (5) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Amir Enshaei, Melvin Joy, Ellie Butler, Amy A Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J Harrison, Robin Foà, Josep-María Ribera, Sabina Chiaretti, Renato Bassan, Adele K Fielding, Anthony V Moorman
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study. Blood advances 8 (5) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Elvira Mora, Juan Montoro Gómez, Aitana Balaguer, Montserrat Rovira, Mónica Cabrero, Inmaculada Heras, Josep-María Ribera, Gabriela Antelo, Ana Africa Martin, Oriana Lopez Godino, Anna Torrent Catarineu, Marta Villalba, Pedro Chorão, Miguel A Sanz, Jaime Sanz Caballer, null null
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone marrow transplantation (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Elvira Mora, Juan Montoro Gómez, Aitana Balaguer, Montserrat Rovira, Mónica Cabrero, Inmaculada Heras, Josep-María Ribera, Gabriela Antelo, Ana Africa Martin, Oriana Lopez Godino, Anna Torrent Catarineu, Marta Villalba, Pedro Chorão, Miguel A Sanz, Jaime Sanz Caballer, null null
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone marrow transplantation 59 (8) (2024)
Josep-María Ribera, Mireia Morgades, Jordi Ribera, Pau Montesinos, Isabel Cano-Ferri, Pilar Martínez, Jordi Esteve, Daniel Esteban, María García-Fortes, Natalia Alonso, José González-Campos, Arancha Bermúdez, Anna Torrent, Eulàlia Genescà, Clara Maluquer, Joaquín Martínez-López, Ramón García-Sanz
Ponalfil trial for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: Long-term results. HemaSphere 8 (4) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Romain Guieze, Diderik-Jan Eikema, Linda Koster, Johannes Schetelig, Henrik Sengeloev, Jakob R Passweg, Juergen Finke, Mutlu Arat, Annoek E C Broers, Friedrich Stölzel, Jenny Byrne, Cristina Castilla-Llorente, Peter Dreger, Matthias Eder, Tobias Gedde-Dahl, Nicolaus M Kröger, Josep-María Ribera, Deborah Richardson, Alessandro Rambaldi, Lucrecia Yañez, Michel Van Gelder, Joanna Drozd-Sokołowska, Kavita Raj, Ibrahim Yakoub Agha, Olivier Tournilhac, Donal P McLornan
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (7) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Josep-María Ribera
MRD: also for T-lymphoblastic lymphoma. Blood 143 (20) (2024)
Hagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, Marlise R Luskin, Matthias Stelljes, Anjali S Advani, Elias J Jabbour, Josep-María Ribera, David I Marks
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions. Cancer (2024)
Josep-María Ribera
JZP458 closes the asparaginase allergy gap. Blood 141 (7) (2023)
Anna Torrent Catarineu, Mireia Morgades, Olga García-Calduch, María Paz Queipo de Llano, Pau Montesinos, Irene Navarro, Jesús María Hernández-Rivas, Abelardo Bárez-García, José González-Campos, Itziar Oiartzabal, Marta Valero, Marta Cervera, Teresa Zudaire Ripa, Manuel Albors-Ferreiro, Oriana Lopez-Godino, Cristina Gil-Cortés, Lucía Villalón, Raquel Saldaña, Josep-María Ribera
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. European journal of haematology (2023)
Maria Huguet, Jose-Tomás Navarro, José Moltó, Josep-María Ribera, Gustavo Tapia
Diffuse Large B-Cell Lymphoma in the HIV Setting. Cancers 15 (12) (2023)
Josep-María Ribera
JZP458 closes the asparaginase allergy gap. Blood 141 (7) (2023)
Maria Huguet, Jose-Tomás Navarro, José Moltó, Josep-María Ribera, Gustavo Tapia
Diffuse Large B-Cell Lymphoma in the HIV Setting. Cancers 15 (12) (2023)
Glenn J Hanna, Anastasios Stathis, Elena Lopez-Miranda, Fabricio Racca, Doris V Quon, Serge Leyvraz, Dagmar Hess, Bhumsuk Keam, Jordi Rodon Ahnert, Myung-Ju Ahn, Hye Ryun Kim, Andreas Schneeweiß, Josep-María Ribera, Daniel J DeAngelo, Jose Manuel Perez Garcia, Javier Cortes, Oliver Schönborn-Kellenberger, Dirk Weber, Pavel Pisa, Michael Bauer, Laura Beni, Maria Bobadilla, Raj Lehal, Michele Vigolo, Florian D Vogl, Elena Garralda
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors. Cancer research communications 3 (9) (2023)
Amir Enshaei, Melvin Joy, Ellie R Butler, Amy A Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J Harrison, Robin Foà, Josep-María Ribera, Sabina Chiaretti, Renato Bassan, Adele K Fielding, Anthony V Moorman
A robust and validated integrated prognostic index for defining risk groups in adult ALL: A EWALL collaborative study. Blood advances (2023)
Josep-María Ribera
T-ALL in CNS-3 status needs improvement. Blood 141 (15) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Josep-María Ribera
JZP458 closes the asparaginase allergy gap. Blood 141 (7) (2023)
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-María Ribera, Juan-Manuel Sancho, Jose-Tomás Navarro
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature. Clinical case reports 11 (5) (2023)
Christelle Ferra Coll, Mireia Morgades, Laura Prieto García, Carlos Pinho Vaz, María Inmaculada Heras Fernando, Rebeca Bailen Almorox, García-Cadenas Irene, Marisa Calabuig, Teresa Zudaire Ripa, Joud Zanabilli, Sandra Novoa, Beatriz Aguado Bueno, Anna Torrent Catarineu, Oriana Lopez-Godino, Rodrigo Martino Bofarull, Mi Kwon, Antonio Campos Júnior, Dolores Caballero Barrigón, Josep-María Ribera
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. European journal of haematology (2023)
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-María Ribera, Juan-Manuel Sancho, Jose-Tomás Navarro
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature. Clinical case reports 11 (5) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Josep-María Ribera, Thibaud Prawitz, Andreas Freitag, Anuj Sharma, Balázs Dobi, Federica Rizzo, Lorenzo Sabatelli, Petros Patos
Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison. Advances in therapy (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Josep-María Ribera
JZP458 closes the asparaginase allergy gap. Blood 141 (7) (2023)
Josep-María Ribera, Olga García, Buenaventura Buendía-Ureña, Maria-José Terol, Ana Vicent, Ferran Vall-Llovera, Juan-Miguel Bergua, Irene García-Cadenas, Aleksandra Holowiecka, Jordi Ribera, Evelyn Acuña-Cruz, Pilar Herrera, Jesus-Maria Hernández-Rivas, Pau Abrisqueta, José González-Campos, Carlos Rodríguez, Mariana Bastos-Oreiro, Eulàlia Genescà, Nerea Caminos, Maria-Paz Queipo de Llano, Antònia Cladera, Juan-Manuel Sancho, null null
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain. Leukemia & lymphoma 63 (8) (2022)
Clara Bueno, Susana Barrera, Alex Bataller, Valentín Ortiz-Maldonado, Natalina Elliot, Sorcha O'Byrne, Guanlin Wang, Montse Rovira, Francisco Gutierrez-Agüera, Juan L Trincado, María González-González, Mireia Morgades, Marc Sorigue, Paloma Bárcena, Samanta Romina Zanetti, Montserrat Torrebadell, Nerea Vega-García, Susana Rives, Mar Mallo, Francisco Solé, Adam J Mead, Irene Roberts, Supat Thongjuea, Bethan Psaila, Manel Juan, Julio Delgado, Alvaro Urbano-Ispizúa, Josep-María Ribera, Alberto Orfao, Anindita Roy, Pablo Menendez
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies. Blood 140 (1) (2022)
Josep-María Ribera, Olga García-Calduch, Jordi Ribera, Pau Montesinos, Isabel Cano-Ferri, Pilar Martínez, Jordi Esteve, Daniel Esteban, María García-Fortes, Natalia Alonso, José González-Campos, Arancha Bermúdez, Anna Torrent, Eulàlia Genescà, Santiago Mercadal, Joaquín Martínez-Lopez, Miriam Santero
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood advances 6 (18) (2022)
Josep-María Ribera, Sabina Chiaretti
Modern Management Options for Ph+ ALL. Cancers 14 (19) (2022)
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alberto López-García, Sylvain Lamure, Federico Itri, Maria Gomes da Silva, Giulia Dragonetti, Iker Falces-Romero, Jaap A van Doesum, Uluhan Sili, Jorge Labrador, Maria Calbacho, Yavuz Bilgin, Barbora Weinbergerová, Laura Milena Serrano Gomez, Josep-María Ribera, Sandra Malak, Jose Loureiro Amigo, Andreas Glenthoej, Raul Cordoba, Raquel Nunes Rodrigues, Tomas Jose Gonzalez-Lopez, Linda Katharina Karlsson, Maria-Jose Jimenez, Jose-Ángel Hernández-Rivas, Ozren Jaksic, Zdenek Racil, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai N Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Oliver Andreas Cornely
COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA. Blood (2021)
Albert Ortiol, Laura Abril, Anna Torrent, Gladys Ibarra, Josep-María Ribera
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma. Therapeutic advances in hematology 12 (2021)
Celia González-Gil, Jordi Ribera, Josep-María Ribera, Eulàlia Genescà
The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia. Genes 12 (1) (2021)
Josep-María Ribera, Mireia Morgades, Eulàlia Genescà, Eduardo-Cerello Chapchap, Pau Montesinos, Evelyn Acuña-Cruz, Cristina Gil, Irene García-Cadenas, Pere Barba, José González-Campos, María-Paz Queipo de Llano, Anna Torrent, Jordi Ribera, Isabel Granada, Teresa Bernal, Marina Díaz-Beyá, María-Luz Amigo, Rosa Coll, Mar Tormo, Ferran Vall-Llovera, Ignacio Gómez-Centurión, María-José Sánchez-Sánchez, Beatriz Soria, Antonia Cladera, María-Teresa Artola, Antoni Garcia-Guiñon, Alberto Giménez-Conca, María-Lourdes Amador, Pilar Martínez-Sánchez, Jesús-Lorenzo Algarra, María-Jesús Vidal, Natalia Alonso, Clara Maluquer, Laura Llorente, Raimundo García-Boyero, Juana Ciudad, Evarist Feliu, Alberto Orfao, null null
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials. Hematological oncology 39 (4) (2021)
José Luis Piñana, Lourdes Vázquez, Rodrigo Martino Bofarull, Rafael de la Cámara, Anna Sureda, Rebeca Rodríguez-Veiga, Ana Garrido, Marta Pratcorona, Josep-María Ribera, Anna Torrent, Maria-Victoria Mateos-Manteca, Javier de la Rubia, María Del Mar Tormo Díaz, María Díez-Campelo, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Juan-Manuel Sancho, Alejandro MartínGarcía-Sancho, Lucrecia Yañez, José Antonio Pérez Simón, Pere Barba, Pau Abrisqueta, Iván Álvarez-Twose, Santiago Bonanad, Ramón Lecumberri, Isabel Ruiz-Camps, David Navarro, José-Ángel Hernández-Rivas, Ángel Cedillo, Ramón García-Sanz, Francesc Bosch
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Leukemia & lymphoma (2021)
Fréderic Baron, Myriam Labopin, Annalisa Ruggeri, Jorge Sierra, Stephen Robinson, Hélène Labussière-Wallet, Michael Potter, Josep-María Ribera, Eric Deconinck, Alessandro Rambaldi, Pierre-Simon Rohrlich, Thierry de Revel, Eliane Gluckman, Arnon Nagler, Mohamad Mohty
Impact of detectable measurable residual disease on umbilical cord blood transplantation. American journal of hematology 95 (9) (2020)
Josep-María Ribera, Eulalia Genescà, Jordi Ribera
Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab. Therapeutic advances in hematology 11 (2020)
Josep-María Ribera, Alejandra de Andrés Saldaña, Nuria García-Muñoz, Joana Gostkorzewicz, Diana Martínez Llinàs, Cristina Díaz de Heredia
Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain. ClinicoEconomics and outcomes research : CEOR 12 (2020)
Josep-María Ribera, Mireia Morgades, Pau Montesinos, Mar Tormo, Daniel Martínez-Carballeira, José González-Campos, Cristina Gil, Pere Barba, Raimundo García-Boyero, Rosa Coll, María Pedreño, Jordi Ribera, Santiago Mercadal, Susana Vives, Andrés Novo, Eulàlia Genescà, Jesús-María Hernández-Rivas, Juan Bergua, María-Luz Amigo, Ferran Vall-Llovera, Pilar Martínez-Sánchez, María Calbacho, Irene García-Cadenas, Antoni Garcia-Guiñon, María-José Sánchez-Sánchez, Marta Cervera, Evarist Feliu, Alberto Orfao, null null
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial. Cancer medicine 9 (7) (2020)
Max S Topp, Nicola Gökbuget, Gerhard Zugmaier, Anthony S Stein, Hervé Dombret, Yuqi Chen, Josep-María Ribera, Ralf C Bargou, Heinz-August Horst, Hagop M Kantarjian
Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab. Cancer 127 (4) (2020)
Josep-María Ribera, Olga García, María-José Moreno, Pere Barba, Irene García-Cadenas, Santiago Mercadal, Pau Montesinos, Manuel Barrios, José González-Campos, Daniel Martínez-Carballeira, Cristina Gil, Jordi Ribera, Susana Vives, Andrés Novo, Marta Cervera, Josefina Serrano, Esperanza Lavilla, Eugenia Abella, Mar Tormo, María-Luz Amigo, María-Teresa Artola, Eulalia Genescà, Pilar Bravo, Daniel García-Belmonte, Antoni García-Guiñón, Jesús-María Hernández-Rivas, Evarist Feliu, null null
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group. Cancer 125 (16) (2019)
Nicola Gökbuget, Hervé Dombret, Sebastian Giebel, Monika Bruggemann, Michael Doubek, Robin Foà, Dieter Hoelzer, Christopher Kim, Giovanni Martinelli, Elena N Parovichnikova, Alessandro Rambaldi, Josep-María Ribera, Marieke Schoonen, Julia M Stieglmaier, Gerhard Zugmaier, Renato Bassan
Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia. Hematology (Amsterdam, Netherlands) 24 (1) (2019)
Alessandro Rambaldi, Josep-María Ribera, Hagop M Kantarjian, Hervé Dombret, Oliver G Ottmann, Anthony S Stein, Catherine A Tuglus, Xiaoyue Zhao, Christopher Kim, Giovanni Martinelli
Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia. Cancer 126 (2) (2019)
Jorge Labrador, Elisa Luño, Edo Vellenga, Salut Brunet, José González-Campos, María Carmen Chillón, Aleksandra Holowiecka, Juan-Miguel Bergua, Juan Bergua, José D González-Sanmiguel, Cristina Gil, María Del Mar Tormo Díaz, Olga Salamero, Felix Manso, Isolda I Fernández, Javier de laSerna, María-José Moreno, Manuel Pérez-Encinas, Isabel Krsnik, Josep-María Ribera, Jose Cervera, María J Calasanz, Blanca Boluda, Marta Anna Sobas, Bob Löwenberg, Miguel A Sanz, Pau Montesinos
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy. Leukemia & lymphoma 60 (5) (2018)
Marta Sobas, Pau Montesinos, Blanca Boluda, Teresa Bernal, Edo Vellenga, Josep F Nomdedéu, Jose González-Campos, Maria Chillón, Aleksandra Holowiecka, Jordi Esteve, Juan Bergua, José David González-Sanmiguel, Cristina Gil-Cortes, María Del Mar Tormo Díaz, Olga Salamero, Felix Manso, Isolda Fernández, Javier de la Serna, María-José Moreno, Manuel Pérez-Encinas, Isabel Krsnik, Josep-María Ribera, Lourdes Escoda, Bob Lowenberg, Miguel Angel Sanz, null null
An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens. Leukemia & lymphoma 60 (4) (2018)
Vicent Guillem, Marisa Calabuig, Salut Brunet, Jordi Esteve, Lourdes Escoda, David Gallardo, Josep-María Ribera, María Paz Queipo de Llano, Montserrat Arnan, Carme Pedro, María Luz Amigo, Josep M Martí-Tutusaus, Antoni García-Guiñón, Joan Bargay, Antonia Sampol, Olga Salamero, Llorenç Font, Carme Talarn, Montserrat Hoyos, Marina Díaz-Beyá, Ana Garrido, Blanca Navarro, Josep Nomdédeu, Jordi Sierra, María Del Mar Tormo Díaz
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival. Leukemia & lymphoma 59 (10) (2018)
Mireia Franch-Sarto, Marc Sorigue, Laia López, Miriam Moreno, Josep-María Ribera, Juan-Manuel Sancho
Overall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab. Leukemia & lymphoma 60 (13) (2018)
Maria Joao Baptista, Gustavo Tapia, Mireia Morgades, Josep Muncunill, Ana-María Muñoz-Marmol, Silvia Montoto, John G Gribben, Maria Calaminici, Antonio Martinez, Blanca Gonzalez-Farre, Ivan Dlouhy, Eva González-Barca, María-José Terol, Pilar Miralles, Miguel Alcoceba, Ferran Vall-Llovera, Javier Briones, Pau Abrisqueta, Eugenia Abella, Mariano Provencio, Carlos García-Ballesteros, José María M Moraleda, Juan-Manuel Sancho, Josep-María Ribera, José-Luis Mate, José-Tomas Navarro
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma. Leukemia & lymphoma 60 (4) (2018)
Josep-María Ribera
Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia. Expert review of hematology 10 (12) (2017)
Marc Sorigue, Edurne Sarrate, Josep-María Ribera, Juan-Manuel Sancho
The case for lymphoma-specific survival. Expert review of hematology 11 (4) (2017)

Josep-María Ribera.css-eqlu8i{font-size:small;padding-left:4px;} (Jose-Maria Ribera, José-María Ribera, Josep Ribera, Josep Maria Ribera Santasusana, Josep María Ribera, Josep-Maria Ribera Santasusana, Josep Maria Ribera, Josep-Maria Ribera)

Publication Activity (10 Years)

Top Topics

Top Venues

Josep-María Ribera (Jose-Maria Ribera, José-María Ribera, Josep Ribera, Josep Maria Ribera Santasusana, Josep María Ribera, Josep-Maria Ribera Santasusana, Josep Maria Ribera, Josep-Maria Ribera)